Exec Summary Patient engagement and patient portals are expected to play an increasingly important role in healthcare by 2030. As...

Exec Summary: The HealthTech IPO market is expected to recover in the summer of 2024 with a number of factors now starting to build and...

Private equity firms have traditionally focused on investing in large, high-growth healthcare technology companies. However, there is a growing opportunity for private equity firms to tap into the midtier of the healthtech landscape. These midtier companies have demonstrated a proof of concept, have won flagship customers, and are consistently profitable. However, they are unlikely to reach billion-dollar valuations. This makes them attractive targets for private equity fi